Article Versions Notes

Vargas-Toscano A, Nickel A-C, Li G, Kamp MA, Muhammad S, Leprivier G, Fritsche E, Barker RA, Sabel M, Steiger H-J, et al. Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide. Cancers. 2020; 12(12):3859. https://doi.org/10.3390/cancers12123859

Vargas-Toscano, Andres, Ann-Christin Nickel, Guanzhang Li, Marcel Alexander Kamp, Sajjad Muhammad, Gabriel Leprivier, Ellen Fritsche, Roger A. Barker, Michael Sabel, Hans-Jakob Steiger, and et al. 2020. "Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide" Cancers 12, no. 12: 3859. https://doi.org/10.3390/cancers12123859

Vargas-Toscano, A., Nickel, A.-C., Li, G., Kamp, M. A., Muhammad, S., Leprivier, G., Fritsche, E., Barker, R. A., Sabel, M., Steiger, H.-J., Zhang, W., Hänggi, D., & Kahlert, U. D. (2020). Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide. Cancers, 12(12), 3859. https://doi.org/10.3390/cancers12123859